Generalized Anxiety Disorder: A Predictor for Poor Responsiveness to Botulinum Toxin Type A Therapy for Pediatric Migraine

  • Ajay Goenka
  • , Sarah Grace Yu
  • , Mahesh Chikkannaiah
  • , Monica Cathryn George
  • , Sarah MacDonald
  • , Adrienne Stolfi
  • , Gogi Kumar

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)21-27
Number of pages7
JournalPediatric Neurology
Volume130
DOIs
StatePublished - May 2022
Externally publishedYes

ASJC Scopus Subject Areas

  • Pediatrics, Perinatology, and Child Health
  • Neurology
  • Developmental Neuroscience
  • Clinical Neurology

Keywords

  • Botulinum toxin type A
  • Generalized anxiety disorder
  • Migraine
  • Pediatrics

Cite this